Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on ...

Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...

Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

A radiation therapist at the Arizona Cancer Institute, sets up the Calypso 4D Localization System to pinpoint radiation for prostate cancer patient.Paul O'Neill / East Valley Tribune / AP Prostate ...

In a population of middle-aged and older men with hypogonadism, "the incidences of high-grade or any prostate cancer and other prostate events were low and did not differ significantly between ...

Medically reviewed by Jamin Brahmbhatt, MDMedically reviewed by Jamin Brahmbhatt, MD What you eat and drink can play an ...

Please provide your email address to receive an email when new articles are posted on . Men with an annual 3% increase in CRF had 35% reduced odds of prostate cancer vs. those with decreased CRF. The ...

A single round of prostate cancer screening that included a prostate-specific antigen (PSA) test, a kallikrein panel, and an MRI detected one additional high-grade cancer per 196 men and one low-grade ...

A new three-phase screening protocol that incorporates a PSA test, a four-kallikrein panel, and an MRI scan appears to improve the prostate cancer detection rate among men invited to participate in a ...

In a recent study published in the journal Prostate Cancer and Prostatic Diseases, researchers investigated the potential associations between human papillomavirus (HPV) infections and prostate ...